top of page

Pluristyx, panCELLa, and Implant Therapeutics Announce Definitive Merger Agreement.

Merger announcement.png

Pluristyx provides the expertise and tools to support and accelerate the development and commercialization of revolutionary therapeutics to treat serious human diseases by providing unique products, consulting, and contract services.

Pluristyx consulting.jpg
Pluristyx services.jpg
Pluristyx cryopreservation.jpg
Pluristyx products.jpg
Pluristyx gene editing.png
bottom of page